Astrazeneca Pharmaceuticals LP v. Wrigley et al

IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF NORTH DAKOTA
ASTRAZENECA PHARMACEUTICALS LP, 	)
)
Plaintiff, 	)
)
v. 	) 	ORDER
DREW H. WRIGLEY, in his official capacity 	)
as the Attorney General of North Dakota; 	)
)
and 	)
)
CAROLYN BODELL, TANYA L. SCHMIDT, 	)
TYLER G. LANNOYE, SHANE R. WENDEL, 	)
KEVIN J. OBERLANDER, DIANE 	)
HALVORSON, and RON HORNER, in their 	)
official capacities as Members of the North 	)
Dakota Board of Pharmacy; and MARK J. 	)
HARDY, in his official capacity as Executive 	) 	Case No. 1:25-cv-182
Director of the North Dakota Board of 	)
Pharmacy, 	)
)
Defendants. 	)
On November 3, 2025, the Parties filed a Joint Motion for Order Adopting Discovery
Protocol. (Doc. No. 24). Attached to the motion is a proposed Discovery Protocol. (Doc. No. 24-1).
The court GRANTS the Parties’ joint motion (Doc. No. 24) and ADOPTS their proposed
Discovery Protocol (Doc. No. 24-1) in its entirety.
IT IS SO ORDERED.
Dated this 4th day of November, 2025.
/s/ Clare R. Hochhalter
Clare R. Hochhalter, Magistrate Judge
United States District Court
Case 1:25-cv-00182-DMT-CRH Document 26 Filed 11/04/25 Page 1 of 1